The Control of Diseases of Tissue Reactivity by Cortisone by Townsley, William
The Control of Diseases of Tissue Reactivity
by Cortisonc
BY WILLIAM TOWNSLEY, M.D.
BELFAST
Formerly Musgrave Research Scholar and Assistant in Pathology,
Queen's University, Belfast
In this paper, a review of the use of cortisone acetate in diseases of tissue reactivity is
given, and particular attention is directed to the author's experience of its application
to one of these diseases-psoriasis.
PATHOLOGY OF PSORIASIS.
THE primary lesion is often a well defined pinhead size papule covered with fine
silvery scales. The individual lesions spread at the periphery and often unite with
other patches to form large plaques and sheets. Histological examination shows
excessive growth of the epithelium with a badly formed horny layer (parakera-
tosis) and a downward growth of the interpapillary processes. As the patch
enlarges healing and hyperparakeratosis occur behind the advancing periphery.
There is a cellular infiltration around the papillary and subpapillary vessels and
leucocytes collect between the horny cells.
AETIOLOGY.
Various causes have been suggested in the past for the appearance of psoriasis
-parasitic agencies, toxins of bacterial and metabolic origin, neuropathic
disturbances, mechanical trauma and heredity.
Psoriasis is a "disease of tissue reactivity," that is the defensive and reparative
processes (whatever the mtiological agent) in the epithelial tissues are active and
the repair constitutes the visible disease. In diseases of tissue reactivity the
common site of involvement is mesenchymal tissue (fibroblasts and reticulo
endothelial elements), but epithelium, where repair and replacement are constantly
necessary, is also affected. Numerous examples of the harmful effects of mesen-
chymal tissue responses to injury, both during the active stages of inflammation
and repair and in the late healed stage, can be found in a clinical survey; uveitis
and rheumatoid arthritis demonstrate distortion of normal morphology and
disturbance of normal function in the eye and joints respectively; fibrosis with
reduction of blood supply in chronic inflammatory lesions prevents immune bodies
and drugs from inhibiting the growth and activity of bacteria in the inflamed area;
fibrosis causes contraction and obstruction of tubes-in the cesophagus,
duodenum, urethra, etc.-and distorts the heart valves in rheumatic fever. Two
examples of diseases of overactivity of the repair process in the epithelial tissue
group are obvious-psoriasis, with its hyperkeratosis, and keloid formation after
burns or injuries.
159Inflammation is basically the same after different forms of injury (Menkin,
1940); it involves the local and the general response-the latter incorporating
stimulation of the pituitary and adrenal glands (Selye, 1946 and 1949). Selye has
given the terms alarm reaction and adaptation mechanism to these changes.
Treatment of these diseases of tissue reactivity, different in atiology but
similar in effect, must be directed at (1) removing the causative agent, where
known; and (2) the control of tissue proliferation. Several research workers have
shown that the administration of cortisone acetate (a secretion of the cortex of
the adrenal gland) or pituitary adrenocorticotrophic hormone, ACTH (which
stimuates the production of cortical hormone), has inhibited the proliferation of
mesenchymal and epithelial tissues (Baker, 1949; Becks, et al., 1944). Baker
demonstrated that ACTH retards wound healing by decreasing the cellularity of
connective tissue and by causing atrophy of collagen fibres, and also that it
determines an atrophy of the epithelial structures-hair, epidermis and sebaceous
glands. Ragan, et al. (1949) observed that ACTH and cortisone retarded fibro-
blast production. It appears, from consideration of various results, that the-
relatively large doses of cortisone given to animals retard wound healing, but
the moderate therapeutic doses (100 mg. daily) given to humans have little notable
effect on incidental wound healing.
Although it may not be possible to suppress the causative agent in many of
these diseases, it is now obvious that the tissue proliferation and exudation may
be controlled-either directly by the oral or parenteral administration of
exogenous cortisone, or indirectly by the injection of ACTH, which stimulates
the adrenal cortex to increase its endogenous hormone production.
Hench (1949) and his co-workers reported the suppressive effect of these
hormones on the tissue reactivity of rheumatoid arthritis. In acute rheumatic fever
and rheumatoid arthritis there is widespread involvement of the mesenchymal
tissues characterized by focal injuries to connective tissue, with aedematous
swelling and degeneration of collagen fibres. The pathological changes in the
subcutaneous nodules of rheumatoid arthritis consist of foci of collagen degenera-
tion similar to the focal changes in anaphylactic hypersensitivity. Cortisone and
ACTH therapy, in patients with rheumatoid arthritis, reduced the fibrous tissue
reaction and gave early relief from pain and increased the mobility of joints. Early
acute cases responded best, because chronic cases showed irreversible bony and
old scar tissue deformities. Laboratory control demonstrated a fall in the red cell
sedimentation rate and a reduction in blood globulin. Albright (1943) has
described the adrenal cortex as anti-anabolic, and it is possible that the fall of
blood globulins after the administration of cortisone may be due to inhibition of
protein synthesis. It is now known that the effect of ACTH and cortisone on
rheumatoid arthritis is confined to a temporary suppression of activity during the
period of treatment and that they have no other effect on the course of the disease
(Freyberg, 1950).
In rheumatic infection the antibodies to haemolytic streptococcal infection arise
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bodies, and it has been stated that these antibodies are the agents which damage
the connective tissues (Gubner, 1949). The effectiveness of cortisone in acute
rheumatic diseases, however, is due to direct action on the mesenchymal connec-
tive tissues and not to suppression of mesenchymal immune bodies-because in
man cortisone does not inhibit antibody formation (Mirick, 1950).
Although cortisone does not inhibit antibody formation in man, a diminution
of antibody response has been demonstrated in animals during its administration
(Bjorneboe, 1951)-possibly due to relatively large doses. The question arises
whether or not cortisone increases susceptibility to infection. Finland (1950)
and co-workers treated pneumococcal pneumonia in man with ACTH and the
general signs of illness were suppressed in twenty-four hours, but the blood and
sputum contained type 8 pneumococci for four days; however, there was no
interference with the normal antibody response. In experimental pneumococcal
infection the results were unfavourable (White and Marshall, 1951). If the diagnosis
between rheumatic fever and subacute bacterial endocarditis, or between non-
infective and pyogenic arthritis (including tuberculosis), is doubtful, antibiotics,
sulphonamides or other drugs lethal to micro-organisms should be administered
before cortisone to avoid the possibility of uncontrolled bacteraemia or
septicoemia.
Cortisone has also been used to depress the reaction of mesenchymal derivates
in certain experimental states-for example, the tuberculin reaction (Stoerck,
1950), the Schwartzman phenomenon (Soffer, et al., 1950) and anaphylaxis
(Dougherty, 1949).
The hypersensitive state-which includes anaphylaxis or serum sickness and
bacterial allergy-has responded well to treatment with cortisone and ACTH.
The hypersensitive state may manifest itself as anaphylaxis (serum sickness)
with degeneration of collagen and spasm of smooth muscle following injection of
egg albumin or foreign serum into an animal sensitized to these proteins, or as
bacterial allergy-a local inflammatory necrotising lesion succeeding the intro-
duction of a specific antigen (for example, tuberculin) in an animal sensitized by
infection with the corresponding organism (tubercle bacillus in this example).
Both anaphylaxis and bacterial allergy are due to the interaction of a sensitizing
antigen with the specific antibody; though fundamentally similar, the results are
different and one can be established independently of the other.
During the process of developing active immunity to infection with bacteria
the body tissues become hypersensitive to the protein of the attacking organisms.
Subsequently, the tissues will suffer severe local damage by small amounts of the
bacterial protein which are harmless to a normal body. Rich has stressed the fact
that immunity and allergy are separate and distinct phenomena. Bacterial allergy
may be seen in many infections-streptococcal, pneumococcal, straphylococcal, etc.
Anaphylaxis and bacterial allergy differ in that anaphylaxis can be passively
transferred-that is, the serum of a sensitized animal will make a normal animal
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normal animal. Bacterial allergy does not depend on circulating antibody whereas
anaphylaxis does. In the tuberculin type of allergic reaction the change progresses
slowly over a number of days and occurs within the cells. In the anaphylactic
local reaction necrosis and damage result from (1) increased permeability and
necrosis of vascular endothelium and interference with tissue nutrition; (2)
spasmodic contraction of smooth muscle fibres; (3) degeneration and fragmenta-
tion of collagen. There is often an associated eosinophilia in blood and tissue.
Involvement of vascular endothelium gives rise to such conditions as purpura,
urticaria and angioneurotic cedema; when smooth muscle is affected conditions
like asthma are apparent. The pathological processes in the cells which are the
seat of the reaction are not clear, but there may be released proteolytic enzymes,
histamine or acetyl choline.
Many substances in addition to foreign protein are capable of producing
anaphylactic hypersensitivity-simple chemical substances like iodine and more
complex chemicals like atropine, sulphonamides and penicillin. The simpler sub-
stances may combine with body proteins to form more complex antigens. Carey
(1950) and others proved the efficacy of ACTH and cortisone in treating
patients suffering from various hypersensitivity reactions (exfoliative dermatitis
after iodine therapy, angioneurotic cedema and urticaria after penicillin, and
dermatitis and leucopenia following sulphonamide treatment, etc.).
There is reason to believe that the anaphylactic type of hypersensitivity may be
the cause of the pathological changes in more diseases than those mentioned in the
two preceding paragraphs. Weintraud (1913) and later investigators have
suggested that the focal lesions of rheumatic fever are due to anaphylactic
responses to bacterial products released in the tissues of patients who have been
sensitized by infection. Rich (1943) demonstrated in rabbits sensitized to sterile
horse serum, with anaphylactic sequelae, lesions similar to those of human
rheumatic carditis. He further showed vascular lesions of periarteritis nodosa
following anaphylactic hypersensitivity to serum and sulphonamides. He
emphasised the importance of remembering that both anaphylactic hyper-
sensitivity and the tuberculin type of hypersensitivity may develop during
bacterial infection. For example, in pneumococcal infection the capsular
carbohydrate induces anaphylactic hypersensitivity and the somatic protein causes
the tuberculin type of hypersensitivity. The two hypersensitive states may occur
in infection with hoemolytic streptococci, e.g., Coburn noted in the skins of
rheumatic patients such responses as the immediate wheal and erythema.
The areas of focal damage to connective tissue elements (oedema and degenera-
tion of collagen fibres) in acute rheumatic fever are essentially similar
in microscopic appearance to the tissue damage in local anaphylaxis (including
the Arthus phenomenon). Rich also emphasised the presence of that criterion of
local anaphylaxis, tissue eosinophilia, in myocarditis of rheumatic origin.
Harvey (1950) and his associates administered cortisone and ACTH to
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found dramatic improvement; the cortisone and ACTH blocked the inflammatory
and exudative manifestations. These diseases were non-granulomatous iritis (a
manifestation of bacterial hypersensitivity), sympathetic ophthalmia (hypersen-
sitivity to uveal tract pigment), and tuberculous uveitis (hypersensitivity to
tuberculo-protein).
WNToods and Wood (1950) demonstrated experimentally in rabbits that cortisoile
and ACTH reduced or abolished the inflammatory and exudative phase of the
ophthalmic reaction in bacterial allergy, the ocular protein anaphylactic reaction,
the focal lesions in tuberculous eyes and the non-hypersensitive reaction to
irritants (glycerine and jequirity infusions) instilled into the conjunctiva. The last
experiment-blocking of the non-hypersensitive reaction to chemcial irritation-is
evidence that cortisone acts directly on the mesenchymal tissues and not on the
antigen-antibody reaction.
In diseases where the hypersensitive state is due to invading organisms the
treatment must not be confined to a reduction by cortisone in tissue damage, but
must include an attack on the virulent organisms by antibiotics, sulphonamides or
other: specific forms of therapy. Since cortisone cannot be used indefinitely, its
beneficial effects are greatest in those hypersensitive states which have a limited
duration or in which the infection can be quickly overcome.
It has been stated that cortisone has an anti-hyaluronidase action. Hyaluroni-
dase, the spreading factor of Duran-Reynals (1942), is an enzyme which lowers
the viscosity of hyaluronic acid to that of water. Hyaluronic acid, a secretion of
connective tissue cells, is the ground substance of the tissue spaces and the
precursor of collagen. The spreading factor can be extracted from invasive
bacteria such as staphylococci, pneumococci, and streptococci, from testicular and
malignant tissues and from snake venom.
Turner and Hollander (1950), in a paper on the effect of cortisone in experi-
mental syphilis in rabbits, noted that the syphilomas were small, contained a
tenacious mucoid material (hyaluronic acid) and exhibited a paucity of mononuclear
cells; virulent treponemes multiplied more rapidly than in control experiments
where no cortisone was administered. When cortisone and penicillin were given
together the treponemes were killed rapidly, but the dead micro-organisms were
not removed as quickly as in lesions in animals receiving penicillin only.
Carey (1950) noted a rise in leucocyte count on the third day during treatment of
sulphonamide hypersensitivity with ACTH. Experimental studies have also
(lemonstrated a marked neutrophilia with both ACTH and cortisone.
It has been reported that the increased level of circulating adrenal steroids after
ACTH administration inhibits histamine formation and accelerates its breakdown.
However, intracutaneous injections of histamine have been given to patients under
treatment with ACTH for a variety of diseases and in no case was there any
evidence that the local cutaneous reaction was suppressed. Cortison and ACTH
produce remissions in asthma, but it appears that the beneficial action of the
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and mechanism of the action is not yet known (Carey, 1950).
The excretioni of urinary adrenal corticoids is increased in acute emotional stress,
acute trauma, surgical wounds, physical strain of short duration and pregnancy.
In prolonged stress or trauma there is a fall of urinary corticoids and the nitrogen
loss characteristic of acute trauma is absent. It now appears that the adrenal
cortical hormones mobilize protein, but the fate of the protein depends on the state
of the body as a whole-in acute stress it is deaminated and lost while in chronic
stress and pregnancy (where it passes to the anabolic area of feetus and uterus) it
is retained. The body state may also determine whether or not wound healing will
be retarded when the level of circulating steroids is high.
It has been suggested (Selye, 1949) that there is some degree of antagonism
in the body between the two groups of adrenal cortical hormones, the mineralo-
corticoids (e.g., desoxocortisone) and the glucocorticoids (e.g., cortisone). Selye
states that the mineralocorticoids induce various defensive tissue reactions
(augmentation of granuloma formation and of allergic responses, primarily in
connective tissue, and anabolism). He also claimed that periarteritis nodosa,
malignant nephrosclerosis and morphological changes similar to hypertensive and
rheumatic diseases could be produced experimentally by administration of the
mineralocorticoids desoxocortisone and desoxycorticosterone acetate.
On the contrary the glucocorticoid cortisone and ACTH (which is predomin-
antly a glucocorticotrophic hormone) have an inhibitory effect-diminution of
granuloma formation and of allergic response, inhibition of mitosis in cells (Green,
1951) and catabolism. Their suppressive effect on collagen diseases and hypersen-
sitive states has already been described.
Toxaemia of pregnancy, in part at least, may be due to excessive secretion of
mineralocorticoids and relative deficiency of glucocorticoids. Recent work points
to hyperactivity of the adrenal gland in late pregnancy (Venning, 1946) and a high
urinary level of mineralocorticoids in toxaemia of pregnancy (Tobian, 1949). Moore
and co-workers (1951) decided on the exhibition of cortisone (despite its salt and
water retaining propensities) in a series of eight cases of pregnancy toxzemia. The
clinical results were good-headache was relieved, vision improved, the patients
felt better, and oedema and albuminuria were reduced (though ascites appeared
in some cases), but the effect on blood pressure was disappointing. It seems prob-
able that some cortical steroids mav exert a direct influence on water excretion
independent of electrolytic or vascular changes.
Other effects of cortisone administration are
(a) Cushingoid side effects-associated with increased glucocorticoid excretion
in the urine. Osteoporosis may cause fractures.
(b) Diminution of pituitary adrenocorticotrophic hormone-hence its beneficial
action in the hypercorticism of the adrenogenital syndrome.
(c) Transient hypocorticism following cessation of cortisone therapy.
A test, based on the decrease in circulating eosinophile cells within a few hours
164after injection of ACTH, has been devised (Thorn, et al., 1948) to diagnose
Addison's disease (adrenal cortical insufficiency) or pituitary deficiency. In this
test a single intramuscular injection of 25 mg. of ACTH is given, and a fall of 50
per cent. or more in the value of circulating eosinophile cells four hours later
indicates a satisfactory adrenal cortical response.
The description "diffuse collagen disease" (Klemperer, et al., 1942) has been
applied to several diseases of varied manifestations, but common involvement, the
connective and vascular tissues. They are characterized microscopically by a
general or local vasculitis, thickening of the collagen fibres and swelling of the
ground substance; the terminal picture is often one of fibrinoid degeneration and
necrosis. There is frequently ocular involvement in these diseases-both of the
blood vessels, as in periarteritis nodosa and cranial arteritis, and of the
mesenchymal tissues of the conjunctiva, iris, sclera and choroid as in
rheumatoid arthritis and dermatomyositis.
The following list summarizes the diseases which respond with varying degrees
of success-some of them dramatically-to treatment with cortisone and ACTH.
It has -been divided into groups, but grouping is obviously unsatisfactory because,
for example, periarteritis nodosa is classified under "diffuse collagen diseases,"
and drug rashes under "hypersensitivity state"-yet it is known that hypersensi-
tivity to iodine can produce both periarteritis nodosa and a skin rash.
Diffuse collagen diseases:
Rheumatoid arthritis, rheumatic fever, disseminated lupus erythematosus,
periarteritis nodosa, dermatomyositis, temporal or cranial arteritis, thrombo-
angiitis obliterans, serum sickness, scleroderma, Sch6nlein-Henoch purpura.
Acute inflammatory skin diseases:
Psoriasis, pemphigus, exfoliative dermatitis.
Acute inflammatory eye diseases
Keratitis, iritis, choroiditis, uveitis, optic neuritis, conjunctivitis, sympathetic
ophthalmia.
"Hypersensitive States"
Angioneurotic oedema, bronchial asthma, drug rashes.
Blood disorders:
Acute leukaemia, chronic lymphatic leukemia, Hodgkin's disease, lympho-
sarcoma.
Nephrotic syndrome:
Ulcerative Colitis:
Gout: ADRENAL CORTICAL HORMONES.
The cortex of the adrenal gland secretes three types of hormones.
(a) Compound F like hormones.
(17-Hydroxycorticosterone steroids).
These hormones convert glucose to glycogen in muscles and liver and restore
glycogen that has been used in the reaction to sudden stress or the "alarm"
reaction; mobilize fat as a source of energy; mobilize amine acids from tissue
165proteins partly for providing energy and for conversion to glucose and glycogen
and partly- for protein synthesis in damaged tissues. When the compounds are
administered in large doses the following changes are noted:-(1) increased excre-
tion of nitrogen, potassium, phosphate and calcium; (2) hyperglyemia and
glycosuria; (3) decreased respiratory quotient. Cortisone acetate (11-dehydro-17
hydroxycorticosterone-21-acetate) belongs to this group.
(b) Desoxycorticosterone hormones.
An excess of circulating hormones of this group causes retention of sodium,
chloride and water, increased excretion of potassium, fatigue and electro-
cardiographic changes. Oedema is evident due to water retention. The hormones
of group A (17 hydroxycorticosterone steroids) also produce these electrolytic
changes but in a less marked degree.
(c) Adrenal androgens.
When stimilated to excess secretion they result in masculinization, amenorrhoea
and hirsutism. They are anabolic in character.
TREATMENT WITH CORTISONE OR ACTH.
The following procedure should be adopted in a full clinical and physiological
investigation:-
(1) Restrict sodium chloride and increase potassium intake to avoid cedema.
(2) Record body weight daily-and, if practicable, fluid intake and output.
(3) Read blood pressure values daily, because hypertension may occur from
water retention.
(4) Examine blood films for fall in eosinophile counts.
(5) Test urine for sugar.
(6) Take electrocardiograms twice weekly.
DOSAGE WITH CORTISONE (MERCK).
The dosage for psoriasis-at any rate for early acute cases of psoriasis-is
probably comparable to that for acute rheumatoid arthritis. XVhen a maximal
response is required for early acute rheumatoid arthritis the advised dosage is
100 mg. every 8 hours for 3 doses; then
100 mg. every 12 hours for 2 doses; then
100 mg. every 24 hours for 7 to 14 days.
After that the daily dose should be gradually reduced (by 10 mg. every second
day) until the daily dose is 50 mg. The dosage schedule may then be altered to
100 mg. every other day and this is maintained until the end of the course-which
may extend up to six weeks and involve the use of up to 4 grammes of cortisone.
A rest period of at least four to six weeks is allowed between each course. If the
expected response is not obtained four or five days after initiating the treatment
the dosage should be increased to 100 mg. every 12 hours for 4 doses. Injections
must be given into muscle. Cortisone can also be given orally.
In the case treated by the author, the psoriasis was widespread and chronic and
the total dose of cortisone acetate was small, 1.5 grammes. It was obvious that
no dramatic response would be obtained-as in early acute rheumatoid arthritis
166on full dosage-but it was hoped that- the process of reversal of the pathological
changes would be sufficiently established to prove the efficacy of treatment by
cortisone. The results (described later) indicated that cortisone treatment was
satisfactory-in that it initiated the desired regressive changes in the lesions, and
because the degree of regression-incomplete though it was-was consistent with
the small dosage and the long duration of the disease.
DOSAGE WITH ADRENOCORTICOTROPHIC HORMONE (ACTH).
This hormone from the anterior part of the pituitary gland acts by increasing
the production of the adrenal cortical steroids. The aim of the treatment, as with
the direct introduction of cortisone into the body, is to gain a therapeutic effect
with minimum metabolic disturbance. After the disease has been suppressed the
smallest effective maintenance doses are employed.
In most cases injections of 10 to 25 mg. every six hours of ACTH (Armour) are
required to effect remissions in diseases like rheumatoid arthritis. Unlike cortisone,
ACTH must be given at short intervals (every six hours). If the total daily dose is
given in only one or two injections the response is absent or poor. The injections,
as with cortisone, must be given by the intramuscular route. Usually 12.5 mg.
every six hours for two weeks is sufficient to establish remission, then the dose is
tapered off.
Cortisone and ACTH have recently been used in America by Freybe-rg (1950)
and Hench in the treatment of psoriatic arthritis; they concluded that long standing
cases do not respond fully even with large doses. In early cases of psoriatic
arthritis, the arthritis responded to relatively small doses (10 mg. every six hours)
of ACTH, but in chronic cases the arthritic response was poor even with large
doses. The psoriatic lesions, in contrast with the arthritic lesions, seem to
require much larger doses to effect complete remission-doses of 25 mg. or even
50 mg. every six hours have been needed. Even with these large doses the skin
lesions in chronic cases do not disappear completely.
Gubner (1951) describes the suppressive effect of aminopterin (a folic acid
antagonist) in diseases of reactivity-rheumatoid arthritis and psoriasis-and
demonstrates striking remissions in psoriasis. However, the toxic effects were
also marked, e.g., ulceration of the mouth and abdominal cramps due to suppres-
sion of normal epithelial growth in the mouth and intestinal tract, and alopecia.
Gubner states that the therapeutic and toxic doses are so close as to preclude its
clinical use.
CASE REPORT.
The patient, a man of 40 years of age, had widespread psoriasis covering his
back, chest, abdomen, arms and legs. He has never been free from psoriasis for
the past twenty-two years, and the present widespread condition has existed for
the past fifteen years. He has had relief for short periods (up to two months) on
various occasions by using ultra violet light and tar ointment and stated that if
he attacked one area (e.g., back or chest or arms) vigorously for- fourteen to
twenty-one days with the combined light and tar methods, he could restore the
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four to eight weeks. His method involved using tar ointment night and morning
every day and irradiation with the mercury vapour ultra violet lamp every second
day; the lamp was usually placed fifteen inches from the skin and the period of
irradiation was one minute on each occasion. During restoration to normal, there
appeared erythema of skin and desquamation of the scales, then brown discolora-
tion, and finally, a normal flat appearance where the former raised, red, scaly
patches existed. Lately dithranol ointment gave better results than tar ointment.
He has suffered from hay fever every year. He also complained of lumbago and
sciatica, and these rheumatic affections have troubled him for the past three
months. X-ray examination of the lumbar spine, sacrum, coccyx, pelvis, sacro-
iliac joints and intervertebral spaces showed no abnormalities. Wassermann
reaction was negative. Examination revealed no cardiovascular disease,
nephritis or metabolic disorder (e.g., diabetes).
FAMILY HISTORY.
Various members of his family have had psoriasis; three brothers have inter-
mittently had small lesions; his daughter had fleeting small psoriatic papules; his
paternal grandmother complained of the same condition. His elder brother, like
himself, suffered from hay fever, but his father has been free of psoriasis and hay
fever.
TREATMENT OF THE CASE WITH CORTISONE.
The course consisted of 1,500 mg. (1.5 grammes) of cortisone acetate
(Cortone, Merck) given by intramuscular injection over a period of fourteen
consecutive days. He received 100 mg. once daily except on two days, when
he got 100 mg. morning and evening, and the thirteenth and fourteenth days
when he got 50 mg. each day.
During the first week of treatment he spent most of each day in bed but returned
to work during the second week. He stopped all other forms of treatment, but
from the seventh day used the sun lamp and tar on his right thigh, and tar
ointment only on his right arm. Baths were taken as usual.
His weight was taken each day and varied from 13 stones 4 lbs. to 13 stones
6 lbs. over the course of fourteen days' treatment. It varied between 13-4lbs.
and 13-5 lbs. during the first four days, then rose to 13-6 lbs., and remained at
this level from the fifth to the eleventh day, when slight oedema appeared in the
right ankle. Oedema with slight pitting on pressure appeared on the left ankle on
the following (twelfth) day. The weight fell to 13-5lbs. on the twelfth, thirteenth
and fourteenth days.
The blood pressure was recorded every second day until cedema appeared, then
each day after that manifestation of electrolytic change. The readings were
110 115 120 120 120 120 100 100 100
85 90 90 90 90 90 75 75 75
168It is evident that both the systolic and diastolic pressures rose from the initial
110 120
values - to on the fifth day and remained at that value until cedema
85 90
appeared on the eleventh day. On the following and subsequent days, when oedema
was still present, the systolic and diastolic pressures fell to below their original
100
levels-that is, to -
75
Retention of sodium, chloride and water with oedema may occur early in the
course, but is usually followed by spontaneous diuresis on continued administra-
tion-or as a result of stopping treatment.
Blood pressure and weight rise when sodium, chloride and water retention occur,
hence the increase in weight and elevation of pressure on the fifth day. The fall in
body weight and blood pressure on the twelfth day may have been due to spon-
taneous diuresis about this time. There is also the possibility that the slight
terminal hypotension was due to increased urinary excretion of potassium. No
doubt the electrolytic disturbance with fluid retention was present in the body from
the fifth day although it only became evident in the ankles on the eleventh day
and that coincided with the spontaneous diuresis and reversal towards normal.
The cedema of ankles subsided on the second day after cessation of the treatment.
The patient stopped using table salt from the beginning of the course and used
salt-free foods (as far as possible) after the appearance of cedema in his legs on the
eleventh day. He experienced a feeling of well-being and mental ease throughout
the course of injections. This was not merely due to absence from work and busi.
ness worries, because it persisted throughout the second week when he returned
to his business. He mentioned on the third and eighth days that he felt thirsty.
From the third day he noted that the psoriasis had stopped burning and itching
and that there was a slight decrease in the redness of some of the patches, especially
on his neck. From the eighth day the psoriatic lesions were paler in the centre,
the large crusts and scales had ceased to form and only fine scales were visible.
At the end of the course the lesions showed definite improvement, though not
complete disappearance; the centres of many lesions were paler and any scales
which formed were of a fine powdery type. The right thigh and the right arm,
subjected also to ultra violet light and tar inunctions, showed a more advanced
improvement.
The lumbago and sciatica varied from day to day during the course and on some
days symptoms had almost disappeared. At the end of the course he complained
of some slight pains in the ankles.
Three weeks after the termination of the course of treatment the psoriasis
showed a return to its former state-crusting had reappeared in the form of large
scales, and he felt burning, itching and tightness of the skin.
169SUMMARY AND CONCLUSIONS.
Cortisone acetate is a crystalline substance elaborated by the cortex of the
adrenal gland; its production is stimulated by the adrenocorticotrophic hormone
of the anterior part of the pituitary gland. It was originally named compound E
(also independently described as substance FA and compound F) and was extracted
from beef adrenal glands. Later it was synthesized from a bile acid.
The administration of cortisone is beneficial in the "diseases of tissue
reactivity," that is, the collagen diseases (e.g., acute rheumatic fever and acute
rheumatoidl arthritis), where it suppresses fibroblastic activity and the epithelial
diseases (e.g., psoriasis), where it induces remissions by inhibiting excess epithelial
proliferation.
During treatment with cortisone there is suppression of inflammatory and
exudative responses, but -there is no attack on the factor causing the individual
disease. Cortisone therefore does not cure the disease-it suppresses the prolifera-
tive activity of the host tissues and effects a disappearance of the pathological
lesions during the period of administration and for a few weeks after cessation of
treatment. The remission is temporary and the visible signs of disease return-
unless the disease has run its course or the organisms responsible have been killed
by antibiotics, sulphonamides or other means. The suppression of connecfive
tissue proliferation reduces ultimate morphological distortion and allows thera-
peutic agents to enter chronic inflammatory areas and destroy embedded noxious
Qrganisms. Cortisone is palliative rather than curative.
The aim of treatment with cortisone and ACTH is to-gain a therapeutic response
with minimum metabolic disturbance, and when the signs of disease have gone
the smallest effective dose should be employed. On account of the metabolic
changes (especially those involving blood sugar levels and tissue fluid exchanges)
and psychological alterations, the following conditions have been cited as contra-
indications to cortisone therapy :-Hypertension, congestive heart failure, psychosis,
chronic nephritis, diabetes, Cushing's syndrome and recent surgical wounds. The
total dosage of cortisone in a course is three to four grammes and the course lasts
two to six weeks. The standard dose is 100 mg. once daily by intramuscular injec-
tion for fourteen days, but 100 mg. may be given twice or three times daily for
the first day or two. After fourteen days the daily dose is reduced by 10 mg. every
second or third day, until 50 mg. daily is being given; then 100 mg. are given
every other day.
In the case reported in this paper-widespread chronic psoriasis of twenty-two
years' duration-the total amount of cortisone available was small (1.5 grammes)
and the duration of treatment was short (fourteen days), yet there was a definite
though slight improvement. The improvement manifested itself in the following
changes-pallor of the central parts of the lesions, cessation of burning and itching,
and the conversion of large scales and crust into fine powdery scales. These
changes indicate reversal of the pathological processes in the skin and point to
a more dramatic response in early acute psoriasis-when cortisone becomes more
plentiful.
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REVIEW
GOOD HEALTH WITH DIABETES. By Ian Murray and Margaret B. Muir.
Edinburgh: E. & S. Livingstone Ltd., 16 and 17 Teviot Place. Price 2s.
THIS booklet of for-ty-four pages is full of most useful hints for diabetics. In general, it con-
tains little which can be adversely criticised. In detail, howx-ever, the authors condone the
measurement of diet by eye rather tban by weighing, although they suggest that weighing
should be occasionally used to ensure that the eve is not becoming over-generous in its estimate.
No reference is made to globin insulin.
The booklet should be helpful particularly to the newvlv diagnosed diabetic, as it contains the
answvers to many simple questions which are all too often neither answered nor anticipated by
the non-diabetic medical adviser. C. K. MI.
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